News
Asianet Newsable on MSN21m
Health Canada Approves Novo’s Ozempic to Reduce Risk Of Kidney Function Decline, Cardiovascular Death
The approval from Health Canada for the indications is based on the results of a trial in which Semaglutide 1 mg demonstrated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback